New drug for skin conditions tested in small study

NCT ID NCT06005792

First seen Dec 17, 2025 · Last updated May 15, 2026 · Updated 22 times

Summary

This study tested a new drug called XmAb27564 in 23 people with plaque psoriasis or atopic dermatitis (eczema). The main goal was to see if the drug is safe and tolerable when given as multiple injections. The trial was stopped early, and results are not yet available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Center for Clinical Studies, LTD. LLP

    Webster, Texas, 77598, United States

  • Clinical Trials Research Institute

    Thousand Oaks, California, 91320, United States

  • Driven Research

    Coral Gables, Florida, 33134, United States

  • Innovaderm Research Inc.

    Montreal, Quebec, H2X 2V1, Canada

  • J&S Studies, Inc

    College Station, Texas, 77845, United States

  • San Marcus Research Clinic

    Miami Lakes, Florida, 33104, United States

  • Unison Clinical Trials

    Sherman Oaks, California, 91403, United States

Conditions

Explore the condition pages connected to this study.